Atlas Trials

Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors

Clinical trial NCT06301828 · UNKNOWN

Trial details

NCT number
NCT06301828
Sponsor
Nanjing First Hospital, Nanjing Medical University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Gastrointestinal Neoplasms
Start date
2024-02-21
Primary completion
2025-06-21
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.